- Home
- TRML vs HY Comparison
TRML vs HY Comparison
Compare TRML & HY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- HY
- Stock Information
- Founded
- TRML 2021
- HY 1991
- Country
- TRML United States
- HY United States
- Employees
- TRML N/A
- HY N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- HY Construction/Ag Equipment/Trucks
- Sector
- TRML Health Care
- HY Industrials
- Exchange
- TRML Nasdaq
- HY Nasdaq
- Market Cap
- TRML 598.9M
- HY 691.8M
- IPO Year
- TRML N/A
- HY N/A
- Fundamental
- Price
- TRML $22.75
- HY $37.57
- Analyst Decision
- TRML Strong Buy
- HY Strong Buy
- Analyst Count
- TRML 7
- HY 1
- Target Price
- TRML $50.14
- HY $70.00
- AVG Volume (30 Days)
- TRML 145.9K
- HY 76.5K
- Earning Date
- TRML 08-13-2025
- HY 08-05-2025
- Dividend Yield
- TRML N/A
- HY 3.77%
- EPS Growth
- TRML N/A
- HY N/A
- EPS
- TRML N/A
- HY 1.26
- Revenue
- TRML N/A
- HY $3,950,600,000.00
- Revenue This Year
- TRML N/A
- HY N/A
- Revenue Next Year
- TRML N/A
- HY $0.23
- P/E Ratio
- TRML N/A
- HY $30.30
- Revenue Growth
- TRML N/A
- HY N/A
- 52 Week Low
- TRML $11.56
- HY $34.13
- 52 Week High
- TRML $29.79
- HY $69.28
- Technical
- Relative Strength Index (RSI)
- TRML 67.63
- HY 44.96
- Support Level
- TRML $22.57
- HY $36.11
- Resistance Level
- TRML $24.56
- HY $39.81
- Average True Range (ATR)
- TRML 1.05
- HY 1.09
- MACD
- TRML 0.02
- HY 0.22
- Stochastic Oscillator
- TRML 84.76
- HY 47.30
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.